[This retracts the article DOI: 10.3389/fphar.2020.00270.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8803392 | PMC |
| http://dx.doi.org/10.3389/fphar.2021.840009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
[Retracted] Puerarin improves graft bone defect through microRNA‑155‑3p‑mediated p53/TNF‑α/STAT1 signaling pathway.
Int J Mol Med
October 2024
Department of Stomatology, Mudanjiang Medical University, Affiliated Hongqi Hospital, Mudanjiang, Heilongjiang 157000, P.R. China.
Following the publication of the above paper, it has been drawn to the Editor's attention by a concerned reader that the immunohistochemical assay data shown in Fig. 4B on p. 245 were strikingly similar to data appearing in different form in another article written by different authors at different research institutes that had already been published in the journal prior to the submission of this paper to .
View Article and Find Full Text PDFMicroRNA-155-3p Promotes Breast Cancer Progression Through Down-Regulating CADM1 [Retraction].
Onco Targets Ther
April 2024
[This retracts the article DOI: 10.2147/OTT.S206180.
View Article and Find Full Text PDFRetraction: microRNA-155 Modulates Hepatic Stellate Cell Proliferation, Apoptosis, and Cell Cycle Progression in Rats With Alcoholic Hepatitis the MAPK Signaling Pathway Through Targeting SOCS1.
Front Pharmacol
January 2022
Frontiers Media SA, Lausanne, Switzerland.
[This retracts the article DOI: 10.3389/fphar.2020.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!